carbostyril has been researched along with Colitis, Ulcerative in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allocca, M; Correale, C; Danese, S; Fiorino, G; Furfaro, F; Gabbiadini, R; Gilardi, D; Peyrin-Biroulet, L; Zilli, A | 1 |
| Cai, T; Fan, C; Feng, C; Li, B; Li, H; Sun, H; Tang, W; Xiang, C; Xu, Z; Zhang, Y; Zhao, Y; Zhu, W; Zhu, Z | 1 |
| Jick, S; Troelsen, FS | 1 |
| Danese, S; Olivera, P; Peyrin-Biroulet, L | 1 |
| Matsumoto, S; Shirahama, S; Tsuji, K | 1 |
| D'Haens, G; Löwenberg, M | 1 |
| Furuta, R; Goto, H; Kusugami, K | 1 |
| Ishikawa, T; Kakumu, S; Kasugai, K; Miyata, M; Mori, T; Onishi, M | 1 |
| Kumakura, T; Maeda, T; Mori, T; Nagamoto, H; Nakashima, T; Takai, M | 1 |
| Ando, T; Furuta, R; Goto, H; Ina, K; Ishiguro, K; Kusugami, K; Maeda, O; Watanabe, O | 1 |
| Kawasaki, H; Makiyama, K; Takeshima, F; Zea-Iriarte, WL | 1 |
| Banan, A; Farhadi, A; Fitzpatrick, LR; Keshavarzian, A; Mutlu, E; Zhang, Y | 1 |
3 review(s) available for carbostyril and Colitis, Ulcerative
| Article | Year |
|---|---|
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD.
Topics: Acetates; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Indans; Indoles; Janus Kinase Inhibitors; Oxadiazoles; Piperidines; Pyridines; Pyrimidines; Quinolones; Sphingosine-1-Phosphate Receptors; Triazoles | 2020 |
Novel targets for inflammatory bowel disease therapeutics.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Adhesion Molecules; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Humans; Immunoglobulin Fab Fragments; Infliximab; Natalizumab; Piperidines; Polyethylene Glycols; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinolones; Tumor Necrosis Factor-alpha; Ustekinumab | 2013 |
[Enema therapy for ulcerative colitis patients].
Topics: Abietanes; Alanine; Anesthetics, Local; Betamethasone; Colitis, Ulcerative; Enema; Fatty Acids, Volatile; Humans; Mesalamine; Quinolones; Severity of Illness Index; Sucralfate | 2005 |
2 trial(s) available for carbostyril and Colitis, Ulcerative
| Article | Year |
|---|---|
Rebamipide enemas-new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Alanine; Anti-Ulcer Agents; Colitis, Ulcerative; Drug Resistance; Enema; Female; Humans; Male; Middle Aged; Patient Satisfaction; Quinolones; Severity of Illness Index | 2005 |
Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis.
Topics: Adolescent; Adult; Aged; Alanine; Anti-Ulcer Agents; Colitis, Ulcerative; Enema; Female; Humans; Male; Middle Aged; Quinolones | 2007 |
7 other study(ies) available for carbostyril and Colitis, Ulcerative
| Article | Year |
|---|---|
Discovery of chiral N-2'-aryletheryl-1'-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazolinium.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, Drug; Drug Discovery; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Oxazoles; Phenols; Quinolones; RAW 264.7 Cells; Structure-Activity Relationship; Sulfhydryl Compounds; Tumor Necrosis Factor-alpha | 2021 |
Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Humans; Logistic Models; Male; Metronidazole; Quinolones; Risk Factors; United Kingdom; Young Adult | 2020 |
Next generation of small molecules in inflammatory bowel disease.
Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunologic Factors; Indans; Inflammatory Bowel Diseases; Oxadiazoles; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: open label study.
Topics: Administration, Rectal; Adult; Aged; Aged, 80 and over; Alanine; Colitis, Ischemic; Colitis, Ulcerative; Colon; Colonoscopy; Enema; Fasting; Female; Gastrointestinal Agents; Humans; Length of Stay; Leukocyte Count; Male; Middle Aged; Quinolones; Retrospective Studies; Time Factors; Treatment Outcome; Wound Healing | 2008 |
Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Enema; Indicators and Reagents; Male; Mesalamine; Quinolones; Rats; Rats, Sprague-Dawley | 2005 |
Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative.
Topics: Adult; Alanine; Anti-Ulcer Agents; Colitis, Ulcerative; Enema; Female; Humans; Proctitis; Quinolones | 2000 |
Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide.
Topics: Alanine; Antioxidants; Colitis, Ulcerative; Humans; Neutrophils; Quinolones; Reactive Oxygen Species; Respiratory Burst | 2002 |